Growth Hormone
9
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
Evaluation of the Efficacy of Growth Hormone, EndoSeal MTA Sealer, and Their Combination on Healing of Periapical Pathosis
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
Single Low-Dose of Supplement Amino Acid
The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
Ghrelin, Growth Hormone and Growth Factors at High Altitude